Robot-assisted surgery controls prostate cancer for 10 years

17 July 2014

New research, which was published in the European Urology journal, found that robot-assisted surgery to remove cancerous prostate glands can control the disease for a decade.

The study, led by researchers at Henry Ford Hospital, Michigan, also suggested that using both traditional methods of measuring the severity and possible spread of the cancer and molecular techniques could help create more personalised treatment options for those undergoing the surgery.

Using several standard measures of cancer-treatment success, such as biochemical markers of recurrence, incidence of metastasis or the spread of cancer beyond the prostate, and cancer-specific survival, the team found that 98.8 per cent of the patients survived cancer for ten years after their surgery.

The findings apply to men whose prostate cancer had not spread any further, and the results are comparable to the well-established and more invasive open surgery to remove the entire diseased prostate and some surrounding tissue.

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)